IRIS Accounts Production v26.2.0.496 SC177933 director 1.4.25 31.3.26 31.3.26 Medium entities true false true true false false true true true true true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC1779332025-03-31SC1779332026-03-31SC1779332025-04-012026-03-31SC1779332024-03-31SC1779332024-04-012025-03-31SC1779332025-03-31SC177933ns15:Scotland2025-04-012026-03-31SC177933ns14:PoundSterling2025-04-012026-03-31SC177933ns10:Director12025-04-012026-03-31SC177933ns10:CompanySecretary12025-04-012026-03-31SC177933ns10:PrivateLimitedCompanyLtd2025-04-012026-03-31SC177933ns10:MediumEntities2025-04-012026-03-31SC177933ns10:Audited2025-04-012026-03-31SC177933ns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-04-012026-03-31SC177933ns10:Medium-sizedCompaniesRegimeForAccounts2025-04-012026-03-31SC177933ns10:FullAccounts2025-04-012026-03-31SC177933ns10:RegisteredOffice2025-04-012026-03-31SC177933ns10:Director22025-04-012026-03-31SC17793312025-04-012026-03-31SC17793312024-04-012025-03-31SC177933ns5:CurrentFinancialInstruments2026-03-31SC177933ns5:CurrentFinancialInstruments2025-03-31SC177933ns5:Non-currentFinancialInstruments2026-03-31SC177933ns5:Non-currentFinancialInstruments2025-03-31SC177933ns5:ShareCapital2026-03-31SC177933ns5:ShareCapital2025-03-31SC177933ns5:RevaluationReserve2026-03-31SC177933ns5:RevaluationReserve2025-03-31SC177933ns5:RetainedEarningsAccumulatedLosses2026-03-31SC177933ns5:RetainedEarningsAccumulatedLosses2025-03-31SC177933ns5:ShareCapital2024-03-31SC177933ns5:RetainedEarningsAccumulatedLosses2024-03-31SC177933ns5:RevaluationReserve2024-03-31SC177933ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31SC177933ns5:RevaluationReserve2024-04-012025-03-31SC177933ns5:RetainedEarningsAccumulatedLosses2025-04-012026-03-31SC177933ns5:RevaluationReserve2025-04-012026-03-31SC177933ns5:OwnedOrFreeholdAssetsns5:LandBuildings2025-04-012026-03-31SC177933ns5:PlantMachinery2025-04-012026-03-31SC177933ns5:FurnitureFittings2025-04-012026-03-31SC177933ns5:MotorVehicles2025-04-012026-03-31SC177933ns5:OwnedAssets2025-04-012026-03-31SC177933ns5:OwnedAssets2024-04-012025-03-31SC177933ns5:LeasedAssets2025-04-012026-03-31SC177933ns5:LeasedAssets2024-04-012025-03-31SC177933ns5:HirePurchaseContracts2025-04-012026-03-31SC177933ns5:HirePurchaseContracts2024-04-012025-03-31SC17793322024-04-012025-03-31SC177933ns5:LandBuildings2025-03-31SC177933ns5:PlantMachinery2025-03-31SC177933ns5:FurnitureFittings2025-03-31SC177933ns5:LandBuildings2025-04-012026-03-31SC177933ns5:LandBuildings2026-03-31SC177933ns5:PlantMachinery2026-03-31SC177933ns5:FurnitureFittings2026-03-31SC177933ns5:LandBuildings2025-03-31SC177933ns5:PlantMachinery2025-03-31SC177933ns5:FurnitureFittings2025-03-31SC177933ns5:MotorVehicles2025-03-31SC177933ns5:ComputerEquipment2025-03-31SC177933ns5:ComputerEquipment2025-04-012026-03-31SC177933ns5:MotorVehicles2026-03-31SC177933ns5:ComputerEquipment2026-03-31SC177933ns5:MotorVehicles2025-03-31SC177933ns5:ComputerEquipment2025-03-31SC177933ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-03-31SC177933ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-04-012026-03-31SC177933ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2026-03-31SC177933ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-03-31SC177933ns5:CostValuation2025-03-31SC177933ns5:DisposalsRepaymentsInvestments2026-03-31SC177933ns5:CostValuation2026-03-31SC177933ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-31SC177933ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC177933ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2026-03-31SC177933ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-31SC177933ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2026-03-31SC177933ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-03-31SC177933ns5:HirePurchaseContractsns5:BetweenOneFiveYears2026-03-31SC177933ns5:HirePurchaseContractsns5:BetweenOneFiveYears2025-03-31SC177933ns5:HirePurchaseContracts2026-03-31SC177933ns5:HirePurchaseContracts2025-03-31SC177933ns5:Secured2026-03-31SC177933ns5:Secured2025-03-31SC177933ns5:DeferredTaxation2025-03-31SC177933ns5:DeferredTaxation2025-04-012026-03-31SC177933ns5:DeferredTaxation2026-03-31SC177933ns5:RetainedEarningsAccumulatedLosses2025-03-31SC177933ns5:RevaluationReserve2025-03-31
REGISTERED NUMBER: SC177933 (Scotland)















Strategic Report, Report of the Director and

Financial Statements for the Year Ended 31 March 2026

for

APPLECROSS NURSING HOME LIMITED

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Company Information 1

Strategic Report 2

Report of the Director 3

Report of the Independent Auditors 5

Statement of Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Notes to the Financial Statements 12


APPLECROSS NURSING HOME LIMITED

Company Information
for the Year Ended 31 March 2026







DIRECTOR: L J Coyle


SECRETARY: P Kelly


REGISTERED OFFICE: Glasgow Road
The Hurlet
Glasgow
G53 7TG


REGISTERED NUMBER: SC177933 (Scotland)


SENIOR STATUTORY AUDITOR: Robert Pollock BA CA


AUDITORS: Sharles Audit Limited
Statutory Auditor
29 Brandon Street
Hamilton
ML3 6DA


SOLICITORS: Brodies LLP
110 Queen Street
Glasgow
G1 3BX

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Strategic Report
for the Year Ended 31 March 2026

The director presents her strategic report for the year ended 31 March 2026.

REVIEW OF BUSINESS
In the opinion of the board of directors, the company has achieved excellent results of the year under review, despite the difficult market conditions affecting the sector generally. The results for the financial year reflect continued investment in the business. A summary of results is as follows:

31st March 2026 31st March 2025

Turnover £6,491,122 £5,987,541

Profit after taxation £768,795 £490,720

Gross Profit £2,365,391 £2,199,715

Gross profit percentage 36.44% 36.74%


Shareholders' funds amount to £3,992,236 (2025 - £3,610,294). The directors are confident that the company has sufficient reserves to finance the anticipated levels of activity in the future.

Turnover for the year ended 31 March 2027 is likely to improve, and the board is satisfied that, with tight control of margins generated, careful monitoring of overheads and continued investment in the business coupled with excellent service provision, profitability will continue at satisfactory levels. The directors therefore expect a continued positive financial performance in the normal course going forward.

There have been no events since the balance sheet date that materially affect the financial position of the company.

GOING CONCERN
The directors have assessed the company as having sufficient resources to meet the expected ongoing costs of the business for a period of at least 12 months from the date of signing the financial statements. As a result they have continued to adopt the going concern basis when preparing the financial statements.

PRINCIPAL RISKS AND UNCERTAINTIES
The company operates in the nursing home industry and is therefore subject to the trading cycles that occur in that sector. The market is competitive although the company has a good reputation with local and regulatory authorities and therefore has repeat business and provides specialist care with barriers to entry. The board is confident that the excellent levels of service provided will ensure that the company continues to be competitive in its chosen market.

ON BEHALF OF THE BOARD:





P Kelly - Secretary


2 October 2026

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Report of the Director
for the Year Ended 31 March 2026

The director presents her report with the financial statements of the company for the year ended 31 March 2026.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of nursing home.

DIVIDENDS
On 30 April 2025 interim dividends were voted as follows:-

- Ordinary shares interim dividend of £200 per share

The total of interim dividends paid was £400,000.

DIRECTORS
L J Coyle has held office during the whole of the period from 1 April 2025 to the date of this report.

Other changes in directors holding office are as follows:

M Kelly - resigned 23 March 2026

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and she has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Report of the Director
for the Year Ended 31 March 2026


AUDITORS
The auditors, Sharles Audit Limited, have indicated their willingness to be reappointed for another term and appropriate arrangements have been put in place for them to be deemed reappointed as auditors in the absence of an Annual General Meeting.

ON BEHALF OF THE BOARD:





P Kelly - Secretary


2 October 2026

Report of the Independent Auditors to the Members of
Applecross Nursing Home Limited

Opinion
We have audited the financial statements of Applecross Nursing Home Limited (the 'company') for the year ended 31 March 2026 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2026 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information
The director is responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Applecross Nursing Home Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Director.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page three, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Applecross Nursing Home Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities are instances of non-compliance with laws and regulations. The objectives of our audit are to obtain sufficient appropriate audit evidence regarding compliance with laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, to perform audit procedures to help identify instances of non-compliance with other laws and regulations that may have a material effect on the financial statements, and to respond appropriately to identified or suspected non-compliance with laws and regulations identified during the audit.

In relation to fraud, the objectives of our audit are to identify and assess the risk of material misstatement of the financial statements due to fraud, to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud through designing and implementing appropriate responses and to respond appropriately to fraud or suspected fraud identified during the audit.

However, it is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the entity's operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, the audit engagement team:
- obtained an understanding of the nature of the industry and sector, including the legal and regulatory framework that the company operates in and how the company is complying with the legal and regulatory framework;
- inquired of management, and those charged with governance, about their own identification and assessment of the risks of irregularities, including any known actual, suspected or alleged instances of fraud;
- discussed matters about non-compliance with laws and regulations and how fraud might occur including assessment of how and where the financial statements may be susceptible to fraud.

As a result of these procedures we consider the most significant laws and regulations that have a direct impact on the financial statements are FRS 102, the Companies Act 2006 and tax compliance regulations. We performed audit procedures to detect non-compliances which may have a material impact on the financial statements which included reviewing financial statement disclosures, inspecting correspondence with local tax authorities and evaluating advice received from external tax advisors.

The most significant laws and regulations that have an indirect impact on the financial statements are those in relation to health and safety, employment law, GDPR, anti-money laundering and environmental regulations. We performed audit procedures to inquire of management and those charged with governance whether the company is in compliance with these law and regulations and reviewed any relevant legal correspondence and invoices for evidence of non compliance.

The audit engagement team identified the risk of management override of controls and revenue recognition as the areas where the financial statements were most susceptible to material misstatement due to fraud. Audit procedures performed included but were not limited to performing analytical procedures to identify unusual or unexpected relationships, testing manual journal entries and other adjustments and evaluating the business rationale in relation to significant, unusual transactions and transactions entered into outside the normal course of business, and challenging judgments and estimates applied in the year end accounts.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Applecross Nursing Home Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Robert Pollock BA CA (Senior Statutory Auditor)
for and on behalf of Sharles Audit Limited
Statutory Auditor
29 Brandon Street
Hamilton
ML3 6DA

7 October 2026

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Statement of Comprehensive
Income
for the Year Ended 31 March 2026

2026 2025
Notes £    £   

TURNOVER 6,491,122 5,987,541

Cost of sales 4,125,731 3,787,826
GROSS PROFIT 2,365,391 2,199,715

Administrative expenses 1,155,167 1,253,148
1,210,224 946,567

Other operating income 12,439 10,764
OPERATING PROFIT 5 1,222,663 957,331


Interest payable and similar expenses 6 222,355 260,231
PROFIT BEFORE TAXATION 1,000,308 697,100

Tax on profit 7 231,513 206,380
PROFIT FOR THE FINANCIAL YEAR 768,795 490,720

OTHER COMPREHENSIVE INCOME
Revaluation release - 2,479,052
Income tax relating to other comprehensive
income

13,237

(734,832

)
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

13,237

1,744,220
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

782,032

2,234,940

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Balance Sheet
31 March 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 9 7,916,753 7,998,661
Investments 10 - 1
7,916,753 7,998,662

CURRENT ASSETS
Debtors 11 545,870 379,275
Cash at bank and in hand 854,782 639,986
1,400,652 1,019,261
CREDITORS
Amounts falling due within one year 12 765,590 687,887
NET CURRENT ASSETS 635,062 331,374
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,551,815

8,330,036

CREDITORS
Amounts falling due after more than one
year

13

(3,368,184

)

(3,505,078

)

PROVISIONS FOR LIABILITIES 17 (1,191,305 ) (1,214,664 )
NET ASSETS 3,992,326 3,610,294

CAPITAL AND RESERVES
Called up share capital 18 5 5
Revaluation reserve 19 2,607,610 2,647,319
Retained earnings 19 1,384,711 962,970
SHAREHOLDERS' FUNDS 3,992,326 3,610,294

The financial statements were approved by the director and authorised for issue on 5 October 2026 and were signed by:





L J Coyle - Director


APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Statement of Changes in Equity
for the Year Ended 31 March 2026

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 April 2024 5 746,250 903,099 1,649,354

Changes in equity
Dividends - (274,000 ) - (274,000 )
Total comprehensive income - 490,720 1,744,220 2,234,940
Balance at 31 March 2025 5 962,970 2,647,319 3,610,294

Changes in equity
Dividends - (400,000 ) - (400,000 )
Total comprehensive income - 821,741 (39,709 ) 782,032
Balance at 31 March 2026 5 1,384,711 2,607,610 3,992,326

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Applecross Nursing Home Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. There were no material departures from the standard.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The financial statements have been prepared on a going concern basis.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

• the requirements of Section 7 Statement of Cash Flows;
• the requirement of paragraph 3.17(d);
• the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and
11.48(c);
• the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;
• the requirements of paragraphs 26.18(b), 26.19 to 26.21 and 26.23;
• the requirements of paragraphs 29.28(b) and 29.29;
• the requirement of paragraph 33.7;
• the requirements of paragraph 24(b) of IFRS 6.

Preparation of consolidated financial statements
The financial statements contain information about Applecross Nursing Home Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 400 of the Companies Act 2006 from the requirements to prepare consolidated financial statements as it and its subsidiary undertaking are included by full consolidation in the consolidated financial statements of its parent, Applecross Investments Ltd, c/o Applecross Nursing Home, Levernholm by Hurlet, Glasgow Road, Glasgow, G53 7TG.

Significant judgements and estimates
In the application of the company's accounting policies, management is required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Turnover & revenue recognition
Turnover is derived from nursing and care services supplied by the company.

Turnover is measured at the fair value of nursing and care services supplied, net of discounts and is recognised at the point that the company obtains the right to consideration.

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

3. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - 2% on cost
Plant and machinery - 15% on cost
Fixtures and fittings - 15% on cost
Motor vehicles - 20% on cost

At each balance sheet date, the company reviews the carrying amounts of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Expenditure of £1,000 or more on individual tangible fixed assets is capitalised at cost. Expenditure on assets below this threshold is charged directly to the income account in the period it is incurred.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

3. ACCOUNTING POLICIES - continued

Basic financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS
2026 2025
£    £   
Wages and salaries 3,252,410 3,234,960
Social security costs 389,283 279,839
Other pension costs 269,525 184,140
3,911,218 3,698,939

The average number of employees during the year was as follows:
2026 2025

Management and Administrative 7 7
Nursing and Care Staff 103 103
Kitchen, Domestic, & Maintenance 25 23
135 133

2026 2025
£    £   
Directors' remuneration 6,285 93,937
Directors' pension contributions to money purchase schemes 60,000 60,000

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2026 2025
£    £   
Other operating leases 45,385 33,611
Depreciation - owned assets 166,792 145,922
Depreciation - assets on hire purchase contracts 25,250 6,248
(Profit)/loss on disposal of fixed assets (400 ) 11,540
Auditors' remuneration 9,900 8,280

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2026 2025
£    £   
Bank loan interest 211,383 256,166
Late payment interest 400 570
Hire purchase interest 10,572 3,495
222,355 260,231

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2026 2025
£    £   
Current tax:
UK corporation tax 244,754 120,476
Under/(over) provision prior
years (3,118 ) -
Total current tax 241,636 120,476

Deferred tax:
Deferred tax (10,123 ) 140,449
Over provision in prior years - (54,545 )
Total deferred tax (10,123 ) 85,904

Tax on profit 231,513 206,380

UK corporation tax has been charged at 25% (2025 - 25%).

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

7. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2026 2025
£    £   
Profit before tax 1,000,308 697,100
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2025 - 25%)

250,077

174,275

Effects of:
Expenses not deductible for tax purposes 3,302 1,607
Adjustments to tax charge in respect of previous periods (3,118 ) (54,545 )
Depreciation on assets not ranking for capital allowances 91,404 21,916
Depreciation on qualifying expenditure revalued (64,181 ) 63,127
Group relief (45,971 ) -
Total tax charge 231,513 206,380

Tax effects relating to effects of other comprehensive income

2026
Gross Tax Net
£    £    £   
Revaluation release - 13,237 13,237

2025
Gross Tax Net
£    £    £   
Revaluation in year 2,479,052 (619,763 ) 1,859,289
Underprovision in prior year - (115,069 ) (115,069 )
2,479,052 (734,832 ) 1,744,220

8. DIVIDENDS
2026 2025
£    £   
Ordinary shares of £0.01 each
Interim 400,000 274,000

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

9. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
COST OR VALUATION
At 1 April 2025 7,673,263 229,735 325,763
Additions 89,726 9,728 -
Disposals - - -
At 31 March 2026 7,762,989 239,463 325,763
DEPRECIATION
At 1 April 2025 - 121,148 321,393
Charge for year 133,617 22,266 2,006
Eliminated on disposal - - -
At 31 March 2026 133,617 143,414 323,399
NET BOOK VALUE
At 31 March 2026 7,629,372 96,049 2,364
At 31 March 2025 7,673,263 108,587 4,370

Motor Computer
vehicles equipment Totals
£    £    £   
COST OR VALUATION
At 1 April 2025 247,323 50,713 8,526,797
Additions - 10,680 110,134
Disposals - (2,431 ) (2,431 )
At 31 March 2026 247,323 58,962 8,634,500
DEPRECIATION
At 1 April 2025 48,662 36,933 528,136
Charge for year 25,250 8,903 192,042
Eliminated on disposal - (2,431 ) (2,431 )
At 31 March 2026 73,912 43,405 717,747
NET BOOK VALUE
At 31 March 2026 173,411 15,557 7,916,753
At 31 March 2025 198,661 13,780 7,998,661

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

9. TANGIBLE FIXED ASSETS - continued

Cost or valuation at 31 March 2026 is represented by:

Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
Valuation in 2025 2,595,432 - -
Cost 5,167,557 239,463 325,763
7,762,989 239,463 325,763

Motor Computer
vehicles equipment Totals
£    £    £   
Valuation in 2025 - - 2,595,432
Cost 247,323 58,962 6,039,068
247,323 58,962 8,634,500

If freehold land & buildings had not been revalued they would have been included at the following historical cost:

2026 2025
£    £   
Cost 5,077,831 5,077,831
Aggregate depreciation 1,203,717 1,102,160

Value of land in freehold land and buildings 1,000,000 1,000,000

Freehold land & buildings were valued on an open market basis on 31 March 2025 by Cushman & Wakefield .

If Freehold Property was sold this would result in an additional corporation tax liability of approximately £919,172.

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

9. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 April 2025
and 31 March 2026 204,909
DEPRECIATION
At 1 April 2025 6,248
Charge for year 25,250
At 31 March 2026 31,498
NET BOOK VALUE
At 31 March 2026 173,411
At 31 March 2025 198,661

10. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 April 2025 1
Disposals (1 )
At 31 March 2026 -
NET BOOK VALUE
At 31 March 2026 -
At 31 March 2025 1

11. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 207,427 180,970
Amounts owed by group undertakings 107,500 -
Other debtors 3,579 3,579
Directors' current accounts - 48,758
Prepayments and accrued income 227,364 145,968
545,870 379,275

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Bank loans and overdrafts (see note 14) 152,064 208,904
Hire purchase contracts (see note 15) 27,424 27,424
Trade creditors 50,664 66,838
Amounts owed to group undertakings - 1
Tax 244,754 129,275
Social security and other taxes 68,553 50,397
Other creditors 110,142 84,097
Accrued expenses 111,989 120,951
765,590 687,887

13. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2026 2025
£    £   
Bank loans (see note 14) 3,243,686 3,353,157
Hire purchase contracts (see note 15) 124,498 151,921
3,368,184 3,505,078

14. LOANS

An analysis of the maturity of loans is given below:

2026 2025
£    £   
Amounts falling due within one year or on demand:
Bank loans 152,064 208,904

Amounts falling due between two and five years:
Bank loans 316,192 368,951

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 years by ins talments 2,927,494 2,984,206

15. LEASING AGREEMENTS

Minimum lease payments under hire purchase fall due as follows:

2026 2025
£    £   
Net obligations repayable:
Within one year 27,424 27,424
Between one and five years 124,498 151,921
151,922 179,345

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

16. SECURED DEBTS

The following secured debts are included within creditors:

2026 2025
£    £   
Bank loans 3,395,750 3,562,061
Hire purchase contracts 151,922 179,345
3,547,672 3,741,406

Bank loans and overdraft are secured by a bond and floating charge together with standard security over the Freehold Property.

Hire purchase liabilities are secured over the assets concerned.

Included in bank loans is a Coronavirus Business Interruption Loan of £46,667. This is supported by a 100% guarantee from the UK Government.

17. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax
Other timing differences 866,197 879,433
Accelerated capital allowances 325,108 335,231
1,191,305 1,214,664

Deferred
tax
£   
Balance at 1 April 2025 1,214,664
Provided during year (10,123 )
On revaluation reserve release (13,236 )
Balance at 31 March 2026 1,191,305

APPLECROSS NURSING HOME LIMITED (REGISTERED NUMBER: SC177933)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025

5 Ordinary £1 5 -
2,000 Ordinary £0.01 - 2
1 A £1 - 1
1 B £1 - 1
1 C £1 - 1
5 5

Shares in all classes have rights and entitlements to dividends. Ordinary shares have voting rights. All other classes of share capital do not have voting rights attached.

In the event of liquidation the surplus assets of the Company remaining after the payments of it's liabilities shall be applied in distributing the balance of such assets as follows:

(i) first shareholders of A, B, C, D and E shares in amounts equal to the amounts paid up by them on such shares; and

(ii) second, the holders of the Ordinary shares in proportion to the numbers of the Ordinary shares held by them.

19. RESERVES
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 April 2025 962,970 2,647,319 3,610,289
Profit for the year 768,795 768,795
Dividends (400,000 ) (400,000 )
Revaluation reserve release 52,946 (39,709 ) 13,237
At 31 March 2026 1,384,711 2,607,610 3,992,321

20. RELATED PARTY DISCLOSURES

Roddinghead Investments (No2) Ltd

A company in which L J Coyle is a director and shareholder

During the year the company paid rents of £10,050 (2025 - £5,550) to Roddinghead Investments (No2) Ltd.

These transactions were conducted under normal commercial terms.